IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascular smooth muscle cells induced by angiotensin II by regulating the expression of cell cycle-related proteins

Hu,Qi; Chen,Jing; Zhang,Jing; Xu,Changwu; Yang,Shuo; Jiang,Hong

doi:10.3892/ijmm.2015.2393

IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascular smooth muscle cells induced by angiotensin II by regulating the expression of cell cycle-related proteins

Authors:
- Qi Hu
- Jing Chen
- Jing Zhang
- Changwu Xu
- Shuo Yang
- Hong Jiang
View Affiliations

Affiliations: Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei 430060, P.R. China, Department of Cardiology, The First College of Clinical Medical Sciences, China Three Gorges University, Yichang, Hubei 443000, P.R. China
Published online on: October 27, 2015 https://doi.org/10.3892/ijmm.2015.2393
Pages: 189-196

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The epigenetic modification of vascular smooth muscle cell (VSMC) phenotypic switching, proliferation, migration, apoptosis and extracellular matrix synthesis is known to occur in atherosclerosis. The aim of the present study was to investigate the effects of IOX1, a Jumonji domain-containing 2A (JMJD2A) inhibitor, on regulation of the cell cycle in angiotensin II (Ang II)-stimulated VSMCs and to elucidate the possible mechanisms involved. The proliferation and migration of the Ang II-stimulated VSMCs in the presence or absence of IOX1 were evaluated in vitro. Flow cytometric analysis was used to determine the effects of IOX1 on cell cycle progression. RT-qPCR and western blot analysis were carried out to measure the expression levels of cell cycle-related genes. The trimethylation of histone H3 lysine 9 (H3K9me3) at the promoters of these genes was detected by chromatin immunoprecipitation (ChIP) assay. We confirmed that the JMJD2A levels were increased, whereas the H3K9me3 levels were decreased in the Ang II-stimulated VSMCs. The inhibition of JMJD2A by IOX1 suppressed the Ang II-induced cell proliferation, migration and cell cycle progression by inhibiting cyclin D1 expression and increasing p21 expression. The underlying mechanisms were related to the restoration of the H3K9me3 levels at the promoters of these genes. In conclusion, the findings of our study indicate that IOX1 exerts its anti-proliferative and anti-migratory effects by regulating the expression of the cell cycle-related proteins, cyclin D1 and p21.

View Figures

View References

1	Libby P, Ridker PM and Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
2	Doran AC, Meller N and McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 28:812–819. 2008. View Article : Google Scholar : PubMed/NCBI
3	King RW, Jackson PK and Kirschner MW: Mitosis in transition. Cell. 79:563–571. 1994. View Article : Google Scholar : PubMed/NCBI
4	Weiss D, Sorescu D and Taylor WR: Angiotensin II and atherosclerosis. Am J Cardiol. 87:25C–32C. 2001. View Article : Google Scholar : PubMed/NCBI
5	Mehta PK and Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 292:C82–C97. 2007. View Article : Google Scholar
6	Klein EA and Assoian RK: Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci. 121:3853–3857. 2008. View Article : Google Scholar : PubMed/NCBI
7	Chen Z, Zang J, Kappler J, Hong X, Crawford F, Wang Q, Lan F, Jiang C, Whetstine J, Dai S, et al: Structural basis of the recognition of a methylated histone tail by JMJD2A. Proc Natl Acad Sci USA. 104:10818–10823. 2007. View Article : Google Scholar : PubMed/NCBI
8	Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M and Shi Y: Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell. 125:467–481. 2006. View Article : Google Scholar : PubMed/NCBI
9	Zhang J, Chen J, Yang J, Xu C, Ding J, Yang J, Guo Q, Hu Q and Jiang H: Sodium ferulate inhibits neointimal hyperplasia in rat balloon injury model. PLoS One. 9:e875612014. View Article : Google Scholar : PubMed/NCBI
10	Shin S and Janknecht R: Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun. 359:742–746. 2007. View Article : Google Scholar : PubMed/NCBI
11	Kogure M, Takawa M, Cho HS, Toyokawa G, Hayashi K, Tsunoda T, Kobayashi T, Daigo Y, Sugiyama M, Atomi Y, et al: Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition. Cancer Lett. 336:76–84. 2013. View Article : Google Scholar : PubMed/NCBI
12	Ding X, Pan H, Li J, Zhong Q, Chen X, Dry SM and Wang CY: Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis. Sci Signal. 6:ra282013. View Article : Google Scholar : PubMed/NCBI
13	Berry WL, Shin S, Lightfoot SA and Janknecht R: Oncogenic features of the JMJD2A histone demethylase in breast cancer. Int J Oncol. 41:1701–1706. 2012.PubMed/NCBI
14	Kauffman EC, Robinson BD, Downes MJ, Powell LG, Lee MM, Scherr DS, Gudas LJ and Mongan NP: Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog. 50:931–944. 2011. View Article : Google Scholar : PubMed/NCBI
15	Kim TD, Shin S, Berry WL, Oh S and Janknecht R: The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. J Cell Biochem. 113:1368–1376. 2012. View Article : Google Scholar
16	Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E and Dangond F: Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J Biol Chem. 280:28507–28518. 2005. View Article : Google Scholar : PubMed/NCBI
17	Zhang D, Yoon HG and Wong J: JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol Cell Biol. 25:6404–6414. 2005. View Article : Google Scholar : PubMed/NCBI
18	Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L and Natarajan R: Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA. 105:9047–9052. 2008. View Article : Google Scholar : PubMed/NCBI
19	Weng X, Cheng X, Wu X, Xu H, Fang M and Xu Y: Sin3B mediates collagen type I gene repression by interferon gamma in vascular smooth muscle cells. Biochem Biophys Res Commun. 447:263–270. 2014. View Article : Google Scholar : PubMed/NCBI
20	Lockman K, Taylor JM and Mack CP: The histone demethylase, Jmjd1a, interacts with the myocardin factors to regulate SMC differentiation marker gene expression. Circ Res. 101:e115–e123. 2007. View Article : Google Scholar : PubMed/NCBI
21	Chen D, Liu J, Rui B, Gao M, Zhao N, Sun S, Bi A, Yang T, Guo Y, Yin Z and Luo L: GSTpi protects against angiotensin II-induced proliferation and migration of vascular smooth muscle cells by preventing signal transducer and activator of transcription 3 activation. Biochim Biophys Acta. 1843:454–463. 2014. View Article : Google Scholar
22	Kim JE and Choi HC: Losartan inhibits vascular smooth muscle cell proliferation through activation of AMP-activated protein kinase. Korean J Physiol Pharmacol. 14:299–304. 2010. View Article : Google Scholar : PubMed/NCBI
23	Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, Versteeg R and Caron HN: Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res. 68:2599–2609. 2008. View Article : Google Scholar : PubMed/NCBI
24	Tsaousi A, Williams H, Lyon CA, Taylor V, Swain A, Johnson JL and George SJ: Wnt4/β-catenin signaling induces VSMC proliferation and is associated with intimal thickening. Circ Res. 108:427–436. 2011. View Article : Google Scholar : PubMed/NCBI
25	Musgrove EA: Cyclins: roles in mitogenic signaling and oncogenic transformation. Growth Factors. 24:13–19. 2006. View Article : Google Scholar : PubMed/NCBI
26	Lachner M, O'Carroll D, Rea S, Mechtler K and Jenuwein T: Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 410:116–120. 2001. View Article : Google Scholar : PubMed/NCBI
27	Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT and Brown PH: The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene. 27:366–377. 2008. View Article : Google Scholar
28	Shaulian E and Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002. View Article : Google Scholar : PubMed/NCBI
29	Schiller R, Scozzafava G, Tumber A, Wickens JR, Bush JT, Rai G, Lejeune C, Choi H, Yeh TL, Chan MC, et al: A cell-permeable ester derivative of the JmjC histone demethylase inhibitor IOX1. ChemMedChem. 9:566–571. 2014. View Article : Google Scholar : PubMed/NCBI
30	King ON, Li XS, Sakurai M, Kawamura A, Rose NR, Ng SS, Quinn AM, Rai G, Mott BT, Beswick P, et al: Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors. PLoS One. 5:e155352010. View Article : Google Scholar : PubMed/NCBI